Robot-assisted Versus Open Lateral Pancreaticojejunostomy for the Treatment of Symptomatic Chronic Pancreatitis (PANACOTTA)

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Status

Enrolling

Conditions

Pancreaticojunostomy

Chronic Pancreatitis

Minimally Invasive Surgical Technique

Robot Surgery

Surgery

Robot Surgica

Minimally Invasive Surgery

Treatments

Procedure: Open lateral pancreaticojejunostomy

Procedure: Robot-assisted lateral pancreaticojejunostomy

Study type

Interventional

Funder types

Other

Identifiers

NCT07109180

NL87297.018.24

Details and patient eligibility

About

PANACOTTA is a multicenter randomized controlled trial including patients with symptomatic chronic pancreatitis and a dilated main pancreatic duct to either robot-assisted or open lateral pancreaticojejunostomy. The PANACOTTA trial will assess the post-operative quality of recovery following robot-assisted versus open lateral pancreaticojejunostomy.

Enrollment

28 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

At least 18 years old
Indication for (extended or partial) lateral pancreaticojejunostomy as agreed during multidisciplinary team meeting based on symptomatic chronic pancreatitis (i.e. morphine dependent pain or recurrent acute flares of pancreatitis, at least 3 episodes per year) and a dilated pancreatic duct of ≥ 5 mm, with a non-enlarged pancreatic head < 40 mm
Confirmed CP, according to the M-ANNHEIM diagnostic Criteria24
Eligible for both an robot-assisted and open approach
Obtained written informed consent

Exclusion criteria

Suspected or confirmed current pancreatic cancer
ASA classification ≥ 4
Other painful conditions aside from CP, with pain difficult to discriminate from CP pain
Prior pancreatic surgery
Pregnancy